36330-86-6 Usage
Description
4-OXO-4-(4-PHENOXYPHENYL)BUTYRIC ACID, also known as (4-Phenoxy) butyric acid or 4-oxo-4-(4-phenoxyphenyl)butanoic acid, is a synthetic organic compound derived from butyric acid with a molecular formula of C16H16O4. It is characterized by its functional groups and versatile reactivity, making it a valuable building block in the synthesis of pharmaceuticals and other organic compounds. Additionally, it exhibits potential anti-inflammatory and anti-cancer properties, which has garnered interest in research for its potential medical applications.
Uses
Used in Pharmaceutical Industry:
4-OXO-4-(4-PHENOXYPHENYL)BUTYRIC ACID is used as a building block for the synthesis of various pharmaceuticals due to its functional groups and versatile reactivity. Its ability to be incorporated into complex molecular structures makes it a valuable component in the development of new drugs.
Used in Organic Chemistry Research:
In the field of organic chemistry, 4-OXO-4-(4-PHENOXYPHENYL)BUTYRIC ACID is used as a starting material for the synthesis of a wide range of organic compounds. Its reactivity and functional groups allow for the creation of diverse chemical entities, contributing to the advancement of organic chemistry.
Used in Anti-inflammatory Applications:
4-OXO-4-(4-PHENOXYPHENYL)BUTYRIC ACID is used as a potential anti-inflammatory agent due to its ability to modulate inflammatory pathways. Its potential to alleviate inflammation makes it a subject of interest for the development of treatments for various inflammatory conditions.
Used in Anti-cancer Research:
In the realm of anti-cancer research, 4-OXO-4-(4-PHENOXYPHENYL)BUTYRIC ACID is used as a compound with potential anti-cancer properties. Its ability to target and inhibit cancer cell growth and proliferation is being investigated for the development of novel cancer therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 36330-86-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,3,3 and 0 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 36330-86:
(7*3)+(6*6)+(5*3)+(4*3)+(3*0)+(2*8)+(1*6)=106
106 % 10 = 6
So 36330-86-6 is a valid CAS Registry Number.
InChI:InChI=1/C16H14O4/c17-15(10-11-16(18)19)12-6-8-14(9-7-12)20-13-4-2-1-3-5-13/h1-9H,10-11H2,(H,18,19)
36330-86-6Relevant articles and documents
Synthesis of Some Novel Thiazolo[3,2-a]pyrimidine and Pyrimido[2,1-b][1,3]thiazine Derivatives and their Antimicrobial Evaluation
Behalo, Mohamed S.
, p. 1391 - 1397 (2018)
A 2-(2-Mercapto-4-(4-phenoxyphenyl)-6-(thiophen-2-yl)-1,6-dihydropyrimidin-5-yl) acetic acid was used as a reactive key precursor to design various pyrimidine derivatives such as thiazolo[3,2-a]pyrimidines and pyrimido[2,1-b][1,3]thiazines. The chemical s
PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS
-
Page/Page column 339-341, (2020/10/18)
This disclosure provides pharmaceutical compounds to treat medical disorders, such as complement-mediated disorders, including complement Cl -mediated disorders.
Design, Synthesis, and Pharmacological Screening of Pyridazinone Hybrids as Anticonvulsant Agents
Partap, Sangh,Yar, Mohammad Shahar,Hassan, Md. Zaheen,Akhtar, Md. Jawaid,Siddiqui, Anees A.
, (2017/10/06)
A series of new hybrid benzimidazole containing pyridazinones derivatives were designed and synthesized in accordance with the pharmacophoric requirements essential for the anticonvulsant activity. The synthesized compounds were evaluated for anticonvulsant activity on mice by the gold standard maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ)-induced seizure models. Among the compounds tested, SS-4F showed significant anticonvulsant activity in both the screens with ED50 values of 25.10 and 85.33 mg/kg in the MES and scPTZ screens, respectively. Compound SS-4F emerged as safer and effective anticonvulsant due to its several-fold higher protective indices. Further, the gamma-aminobutyric acid (GABA) estimation result showed a marked increase in the GABA level (1.7-fold) as compared to the control, which was further confirmed by good binding properties with the GABAA receptor.
